Endonovo Therapeutics (QB) Stock Price

-0.0006 (-3.03%)
Volume 15,734
Bid Price 0.0001
Ask Price 0.0874
News -
Day High 0.0197


52 Week Range


Day Low 0.01793
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Endonovo Therapeutics Inc (QB) ENDV OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0006 -3.03% 0.0192 16:28:17
Open Price Low Price High Price Close Price Prev Close
0.0197 0.01793 0.0197 0.0192 0.0198
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4 15,734 $ 0.019193 $ 302 - 0.0141 - 0.10
Last Trade Time Type Quantity Stock Price Currency
12:31:35 10,000 $ 0.0192 USD


Draw Mode:

Endonovo Therapeutics Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.12M 58.46M 8.99M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.94k $ - - - -

more financials information »

Endonovo Therapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENDV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01910.02060.01520.0198369194,4770.00010.52%
1 Month0.02090.02190.01520.0191138191,418-0.0017-8.13%
3 Months0.02390.0350.01520.0231699225,359-0.0047-19.67%
6 Months0.03190.060.01410.0276467259,740-0.0127-39.81%
1 Year0.0240.100.01410.0370013421,800-0.0048-20.0%
3 Years0.02743.900.00110.01990271,790,912-0.0082-29.93%
5 Years0.05513.900.00110.0318061,871,818-0.0359-65.15%

Endonovo Therapeutics (QB) Description

Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis.

Your Recent History
Endonovo T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.